Tactics and features of the use of instrumental and drug treatment methods in hospitalized patients with COVID-19 and myocardial infarction with ST segment elevation: a literature review
Year: 2026
Type: article
Abstract: Background . The co-occurrence of ST-segment elevation myocardial infarction (STEMI) and COVID-19 poses a significant clinical challenge, characterized by more severe disease, higher thrombotic burden, and worse prognosis. The COVID-19 pandemic has substantially impacted the delivery of care for patients with acute coronary syndromes. Objective . To review current literature analyzing the management strategies, instrumental and pharmacological treatment approaches in hospitalized patients with concomitant COVID-19 and STEMI, and to assess the pandemic's impact on the accessibility and outcomes of reperfusion therapy. Key findings. The review indicates that patients with COVID-19 and STEMI exhibit a higher prevalence of myocardial injury (5–38 %), more pronounced thrombotic burden (multi-vessel thrombosis, stent thrombosis), and impaired coronary microcirculation. The pandemic led to a decrease in STEMI hospitalizations (up to ~20 %), increased time to treatment, and consequently, a rise in complication rates and in-hospital mortality, which reaches 28–41 % in these patients. Despite increased procedural challenges, primary percutaneous coronary intervention (PCI) remains the preferred reperfusion strategy. The role of hypercoagulability and the need for careful tailoring of antithrombotic therapy (including heparins and dual antiplatelet therapy), considering drug interactions with antivirals, are emphasized. Conclusion. Management of STEMI patients with COVID-19 requires a multidisciplinary approach that accounts for heightened thrombogenic risk and systemic inflammation. Optimizing reperfusion timelines, adapting anticoagulation protocols, and maintaining access to invasive procedures are key factors for improving outcomes during the pandemic.
Institution: Pirogov Russian National Research Medical University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: COVID-19 pandemic, ST-elevation myocardial infarction, reperfusion therapy, primary percutaneous coronary intervention, antithrombotic therapy, dual antiplatelet therapy, heparin, hypercoagulability, antiviral drug interactions, stent thrombosis, myocardial injury, in-hospital mortality, time to treatment, hospitalized patients
Open Access status: diamond
OpenAlex ID: W7160240474
